HKMPY
Hikma Pharmaceuticals PLC [HKMPY] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
HKMPY Stock Summary
Top HKMPY Correlated Resources
HKMPY
Top 10 Correlated ETFs
HKMPY
Top 10 Correlated Stocks
HKMPY
In the News
HKMPY Financial details
HKMPY Financial Performance
HKMPY Frequently Asked Questions
What is Hikma Pharmaceuticals PLC stock symbol ?
Hikma Pharmaceuticals PLC is a GB stock and trading under the symbol HKMPY
What is Hikma Pharmaceuticals PLC stock quote today ?
Hikma Pharmaceuticals PLC stock price is $57.48 today.
Is Hikma Pharmaceuticals PLC stock public?
Yes, Hikma Pharmaceuticals PLC is a publicly traded company.
Company Profile
- Volume Average 200
- Market Capitalization 5.23B
- Employee 9.1K
- CEO Mr. Riad Ali Mishlawi
- Headquarters London,GB
- IPO Date 2012-02-07
-
Website
https://www.hikma.com 
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.
